These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32671512)

  • 21. ADC
    Wu L; Xu P; Rao S; Yang L; Chen C; Liu H; Fu C; Zeng M
    J Magn Reson Imaging; 2017 Sep; 46(3):820-830. PubMed ID: 28276105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.
    Vandecaveye V; Michielsen K; De Keyzer F; Laleman W; Komuta M; Op de beeck K; Roskams T; Nevens F; Verslype C; Maleux G
    Radiology; 2014 Mar; 270(3):747-57. PubMed ID: 24475816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The quantitative analysis of MR dynamic contrast-enhangced imaging on efficacy and prognosis of transcatheter arterial chemoembolization on hepatocellular carcinoma].
    Ma XH; Wang S; Zhao XM; Ouyang H; Wang M; Zhu YJ; Zhu Z; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):689-694. PubMed ID: 28926899
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Luo Y; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Zarghampour M; Khoshpouri P; Ameli S; Li Z; Hu D; Kamel IR
    Eur Radiol; 2019 Oct; 29(10):5160-5171. PubMed ID: 30877462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma.
    Ou HY; Cheng YF; Chuang YH; Hsu HW; Chen CL; Lazo MZ; Weng CC; Yu CY; Tsang LL; Huang TL; Tong YS
    Dig Dis Sci; 2020 Aug; 65(8):2433-2441. PubMed ID: 31732907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.
    Liu HF; Zou LQ; Lu XR; Sheng Y; Wang Q; Ding JL; Shi L; Liu SQ; Xing W
    J Magn Reson Imaging; 2020 Oct; 52(4):1019-1028. PubMed ID: 31675170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    Wimmer T; Steiner J; Talakic E; Stauber R; Quehenberger F; Portugaller RH; Schoellnast H
    J Comput Assist Tomogr; 2017; 41(5):708-712. PubMed ID: 28296685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging features predictive of an incomplete response to transarterial chemoembolization in patients with hepatocellular carcinoma: A STROBE-compliant study.
    Kim YJ; Lee MH; Choi SY; Yi BH; Lee HK
    Medicine (Baltimore); 2019 May; 98(19):e15592. PubMed ID: 31083245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE.
    Nörthen A; Asendorf T; Shin HO; Hinrichs JB; Werncke T; Vogel A; Kirstein MM; Wacker FK; Rodt T
    Abdom Radiol (NY); 2018 Dec; 43(12):3288-3300. PubMed ID: 29680967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation.
    Zhang W; Xu AH; Wang W; Wu YH; Sun QL; Shu C
    BMC Cancer; 2019 Nov; 19(1):1041. PubMed ID: 31690274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in hepatocellular carcinoma.
    Yu JY; Zhang HP; Tang ZY; Zhou J; He XJ; Liu YY; Liu XJ; Guo DJ
    Clin Radiol; 2018 Aug; 73(8):758.e9-758.e18. PubMed ID: 29804627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
    Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
    World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
    Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
    Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Posttransarterial Chemoembolization Volumetric Oil Deposition on Computed Tomography Predict Treatment Response on Magnetic Resonance Imaging in Leiomyosarcoma Metastases to the Liver?
    Hazhirkarzar B; Shaghaghi M; Baghdadi A; Ghadimi M; Ghasabeh MA; Wu Q; Tang H; Khoshpouri P; Ameli S; Habibabadi RR; Motaghi M; Meyer CF; Kamel IR
    J Comput Assist Tomogr; 2022 May-Jun 01; 46(3):327-332. PubMed ID: 35405712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.
    Bonekamp D; Bonekamp S; Halappa VG; Geschwind JF; Eng J; Corona-Villalobos CP; Pawlik TM; Kamel IR
    Eur J Radiol; 2014 Mar; 83(3):487-96. PubMed ID: 24387824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
    Nicolini D; Agostini A; Montalti R; Mocchegiani F; Mincarelli C; Mandolesi A; Robertson NL; Candelari R; Giovagnoni A; Vivarelli M
    World J Gastroenterol; 2017 May; 23(20):3690-3701. PubMed ID: 28611522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.